Condition

Type2 Diabetes Mellitus

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 114 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials114
Recruiting4
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

60 shown
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)NCT07654374 · 2026-07-17
RECRUITING
A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes MellitusNCT07619157 · 2026-06-02
RECRUITING
SnapDandCGMinType2DMNCT07533604 · 2026-01-20
RECRUITING
Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLDNCT06449833 · 2024-06-01
RECRUITING
INcreasing the Uptake of DSMES Program and Addressing Social Needs in Low-Income VulneRablE ImmigrantsNCT07296211 · 2026-01-01
NOT_YET_RECRUITING
"Effect of Omega-3 Supplementation as Add on Therapy on Glycemic Control and Lipid Profile in Type2 Diabetes Mellitus."NCT07352618 · 2026-01-01
ENROLLING_BY_INVITATION
Diet and Progression of CKD in Patients With Type 2 Diabetes MellitusNCT07169786 · 2025-10-01
NOT_YET_RECRUITING
Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)NCT07203677 · 2025-09-19
COMPLETED
Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets in Type-2 Diabetes Mellitus PatientsNCT06961019 · 2025-08-25
COMPLETED
A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State StudyNCT07044765 · 2025-08-01
NOT_YET_RECRUITING
A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy AdultsNCT07034781 · 2025-08-01
NOT_YET_RECRUITING
Effects of Marching Exercise With Cognitive Training on Physical, Cognitive Function, and Autonomic Cardiovascular Responses in Older Adults With Type 2 Diabetes MellitusNCT07330700 · 2025-07-10
COMPLETED
Observational Study on GER in Patients With Simple ObesityNCT07188571 · 2025-07-01
COMPLETED
A Study to Assess Effect of Glucocil® on Metabolic Health in Individuals With Prediabetes and Type 2 Diabetes Mellitus.NCT06496893 · 2024-09-12
COMPLETED
Effort During Resistance Training in Type 2 DiabetesNCT06497842 · 2024-09-10
COMPLETED
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With MetforminNCT06257966 · 2024-07-17
ACTIVE_NOT_RECRUITING
Effects of a Health Intervention on Fear of HypoglycemiaNCT06464900 · 2024-07-01
UNKNOWN
A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fed Conditions in Healthy Adult VolunteersNCT06289933 · 2024-03-05
COMPLETED
Bioequivalence Study of Empagliflozin 25 mg Film Coated Tablets of Humanis, Turkey and Jardiance (Empagliflozin) 25 mg Film-coated Tablets of Boehringer Ingelheim International GmbH, Germany in Normal, Healthy, Adult, Human Subjects Under Fasting ConditionNCT06180109 · 2023-07-30
COMPLETED
Nephroprotective Effect of Nicorandil in Type 2 Diabetes MellitusNCT06430125 · 2023-02-28
UNKNOWN
Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes MellitusNCT05762471 · 2023-01-09
COMPLETED
AI Health Assistant and Type 2 DiabetesNCT05539066 · 2022-10-01
UNKNOWN
Web-based Diabetic Foot Care Training Prepared With the Health Belief Model for Type 2 Diabetes PatientsNCT05395442 · 2022-06-03
COMPLETED
The Influencing Factors of 12 Week Efficacy of Polyethylene Glycol Losenatide in Type 2 Diabetes PatientsNCT05611684 · 2022-06-01
UNKNOWN
Effects of Vitamin D Supplementation on SOD,IL-6 and Insulin Resistance in Type 2 Diabetes Mellitus (DM)NCT05596383 · 2022-02-12
UNKNOWN
Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.NCT03766750 · 2021-12-01
WITHDRAWN
High Protein Effect on Body Composition and Sarcopenia Markers in Older Patients With Type 2 Diabetes MellitusNCT05457088 · 2021-11-01
COMPLETED
Empagliflozin Effect on Glucose ToxicityNCT03437330 · 2021-10-27
WITHDRAWN
The Effect of Multidomain Dietary Education in Type 2 Diabetic AdultsNCT05892861 · 2021-06-03
COMPLETED
A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.NCT04810676 · 2021-04-16
COMPLETED
Investigating Plasma Biomarker Molecules Associated With the Progression of Prediabetes to Overt Type 2 DiabetesNCT04851223 · 2021-03-22
UNKNOWN
Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCINCT04481997 · 2021-01-11
COMPLETED
Feasibility of an Online Exercise Community Among Individuals With Type 2 DiabetesNCT05668442 · 2020-11-21
COMPLETED
Diabetes Nutrition Education With Glycemic ControlNCT04440319 · 2020-07-01
COMPLETED
The Metabolic Impact of Bariatric Surgery Compared to Best Diabetic Care on Manitoba's Urban Indigenous PopulationNCT03301545 · 2020-07-01
UNKNOWN
Changes of Muramyl Dipeptide in Intestinal and Extra-intestinal DiseasesNCT04924686 · 2020-05-10
UNKNOWN
Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic AgentsNCT04287387 · 2020-03-02
UNKNOWN
A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396NCT04246190 · 2020-02-24
UNKNOWN
A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult VolunteersNCT04223895 · 2020-02-01
UNKNOWN
A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375NCT04221360 · 2020-01-29
UNKNOWN
Metabolic, Physical Responses To Exercise In Patients With Type 2 Diabetes MellitusNCT03682445 · 2019-11-04
COMPLETED
Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular PreventionNCT04082091 · 2019-09-01
UNKNOWN
Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes MellitusNCT03973515 · 2019-08-27
COMPLETED
Qatar Diabetes Mobile Application TrialNCT03998267 · 2019-08-22
UNKNOWN
Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1NCT04156685 · 2019-08-06
COMPLETED
Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and PediatricsNCT03966911 · 2019-06-14
COMPLETED
Guide To Goals: A Novel Care Coordination Tool for Children With Type Two Diabetes (T2D)NCT03926598 · 2019-06-05
COMPLETED
Tolerance & Responsiveness Improvement for Metformin (TRIM)NCT03670043 · 2019-03-19
COMPLETED
Mil Familias Cohort Establishment: a Study to Understand Determinants of Diabetes and Its Complications Among US LatinosNCT03830840 · 2019-02-01
COMPLETED
STAR Study Investigating Performance and Safety of the Medical Device SiPore15™NCT03823027 · 2019-01-28
COMPLETED
IRAPe, Irisin and IL-34 in Patients With Type 2 DiabetesNCT04107259 · 2019-01-19
COMPLETED
Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy AdultsNCT03849261 · 2019-01-14
UNKNOWN
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver DiseaseNCT03590626 · 2019-01-01
COMPLETED
Exercise Volume and Beta-cell Function in T2D The DOSE-EX Randomized TrialNCT03769883 · 2018-12-12
COMPLETED
The Progress of Diabetes Mellitus After HMS5552 Treatment in Type 2 Diabetes MellitusNCT04091854 · 2018-12-12
UNKNOWN
"POWER2DM Evaluation Campaign"NCT03588104 · 2018-12-03
COMPLETED
Financial Incentives for Low Socioeconomic Diabetic PatientsNCT03506230 · 2018-11-25
UNKNOWN
Diabetes and Osteopathic Manipulative Medicine (OMM)NCT03663322 · 2018-11-15
UNKNOWN
The MHERO Study (Michigan's Hypertension, Diabetes, and Obesity Education Research Online)NCT03729479 · 2018-11-01
COMPLETED
Smectite Gel and Probiotic for Obesity and Insulin ResistanceNCT04293731 · 2018-11-01
COMPLETED

Common interventions

Trial status mix

COMPLETED70
UNKNOWN28
WITHDRAWN5
NOT_YET_RECRUITING4
RECRUITING4
ACTIVE_NOT_RECRUITING2
ENROLLING_BY_INVITATION1

Phase mix

NA49
PHASE121
PHASE39
PHASE48
PHASE27
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.